Key result
The highest tertile of the insulin resistance-nutritional index was associated with a significantly increased risk of all-cause death compared to the lowest tertile (HR 1.93; 95% CI 1.66-2.26; P<0.001).
Why the study?
The combined effect of the triglyceride-glucose index and prognostic nutritional index on mortality risk in patients with chronic heart failure and type 2 diabetes had not yet been studied.
Does the Insulin Resistance-Nutritional Index (IRNI) predict mortality risk in patients with chronic heart failure and type 2 diabetes?
Cohort (n=3,315)
Does the Insulin Resistance-Nutritional Index (IRNI) predict mortality risk in patients with chronic heart failure and type 2 diabetes?
The novel Insulin Resistance-Nutritional Index (IRNI) is a strong predictor of all-cause and cardiovascular mortality in patients with concurrent chronic heart failure and type 2 diabetes.
Background: Patients with chronic heart failure (CHF) and type 2 diabetes mellitus (DM) are prone to insulin resistance and malnutrition, both of which are significant prognostic factors for CHF. However, the combined effect of the triglyceride–glucose index (TyG index) and prognostic nutritional index (PNI) on the mortality risk in patients with CHF and type 2 DM has not yet been studied. Methods: We enrolled 3,315 patients with CHF and type 2 DM. We used a multivariate Cox regression model to assess hazard ratios (HRs) with 95% confidence intervals (CIs) for mortality risk based on TyG index and PNI levels. Furthermore, we constructed a novel index, the insulin resistance–nutritional index (IRNI), defined as TyG index/Ln (PNI), and evaluated its prognostic significance. Results: During follow-up, 1,214 deaths occurred. Participants with a high TyG index and non-high PNI had a significantly higher mortality risk compared to those with a non-high TyG index and high PNI, with an adjusted HR of 1.91 (95% CI, 1.57– 2.32). The multivariate Cox regression analysis revealed HRs for all-cause and cardiovascular deaths of 1.93 (95% CI, 1.66– 2.26; P < 0.001) and 2.50 (95% CI, 2.05– 3.06; P < 0.001), respectively, when comparing the highest and lowest IRNI tertiles. IRNI’s predictive power was stronger in groups with higher adapted Diabetes Complications Severity Index scores ( P for interaction < 0.05). Additionally, adding IRNI to the baseline risk model significantly improved predictive performance, showing a greater effect compared to the TyG index or PNI. Conclusion: IRNI, a novel and composite index reflecting insulin resistance and nutritional status, emerges as a potentially valuable prognostic marker for patients with CHF and type 2 DM.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2024) conducted a cohort in Chronic heart failure and type 2 diabetes mellitus (n=3,315). Insulin resistance-nutritional index (IRNI) vs. Lowest IRNI tertile was evaluated on All-cause death (HR 1.93, 95% CI 1.66-2.26, p=< 0.001). The highest tertile of the insulin resistance-nutritional index was associated with a significantly increased risk of all-cause death compared to the lowest tertile (HR 1.93; 95% CI 1.66-2.26; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: